ARCHIVES

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

In Brief: Cancer Program “Strengthened” NIH, Report From Biomedical Research Panel Contends

April 16, 1976

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

Toxic Wastes And Cancer Linked; NCI Data Questioned In Bay Study

December 13, 1985

Ten Cooperative Group Chairs Propose Eight “Guiding Principles” For Change

May 20, 2011